Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07548632 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
A Phase 2 study, sponsored by Oculis.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT07548632: Recruiting Phase 2 study, sponsored by Oculis.
NCT07548632 is a Phase 2 study that is actively recruiting participants, run by Oculis. The registered enrollment target is 160 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (20% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07548632, a Phase 2 study, is actively recruiting participants, sponsored by Oculis.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Interventions
- OTHER Artificial Tear Run-in
- DRUG licaminlimab
- OTHER Vehicle of licaminlimab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
What NCT07548632 shows while recruiting
NCT07548632 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (20% higher).
The record links to 0 conditions, and to 3 interventions - of which Artificial Tear Run-in is the first listed.
NCT07548632 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07548632 about?
NCT07548632 is a clinical study titled "A Clinical Study Evaluating Licaminlimab for Dry Eye Disease". The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
What is the current status of trial NCT07548632?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2026-04-16. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07548632?
The interventions under investigation include: Artificial Tear Run-in (OTHER), licaminlimab (DRUG), Vehicle of licaminlimab (OTHER).
Who is sponsoring clinical trial NCT07548632?
This trial is sponsored by Oculis, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07548632's enrollment target sits among peer trials
160 422nd of 2000 higher than 1,559 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI